eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention....
.
...
as tick season arrives into full swing in canada, officers in manitoba are warning the citizens that lyme disease is not the only thing to be on the lookout for...